Trial intelligence / Profile preview

Gemcitabine and Radiation for Bulky Cervical Cancer

NCT00184093Phase 2Completed

Sponsor
University of Southern California
Start
Jun 1999
Primary completion
May 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gemcitabine in Cervical Cancer (CC), sponsored by University of Southern California. Started Jun 1999; status: completed.

02

Drugs

gemcitabine
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT00184093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00184093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call